The electrocardiographic QT interval has been extensively studied in ischaemic heart disease. Recently, there has been increasing interest in the relationship between diabetes and QT abnormalities. QT prolongation and increased QTd have been shown to predict cardiac death in both type 1 and type 2 diabetes mellitus. Although there is general agreement that QT interval is affected by cardiac ischaemia, the effect of hyperglycaemia on QT measures is controversial. There are also problems surrounding QTd. First, there is controversy as to whether the measure has any physiological meaning; secondly, there is no universally accepted method of measurement and hence no consensus about the upper limit of normal. Nevertheless, several studies have shown increased QTd in diabetic patients suggesting that assessment of the QT interval could be a cost effective way of stratifying aggressive treatment could be directed appropriately to such patients according to cardiovascular risk so that improve outcome.
Bazett HCAn Analysis of the time relations of electrocardiogramsHeart1920;7:353-70.
2.
Hodges M., Salerno Q., Erlien D.Bazett's QT correction reviewed. Evidence that a linear QT correction for heart rate is better. J Am Coll Cardiol1983 ;1:694
3.
Macfarlane PW, Lawrie TDV.The normal electrocardiogram and vectorcardiogram. In: Macfarlane PW, Lawrie TDV, eds. Comprehensive Electrocardiology. Oxford, UK . Pergamon Press; 1989 ;1:407-57.
4.
Algra A., Tijssen JG, Roelandt JR, Pool J., Lubsen J.QTc prolongation measured by standard 12-lead electrocardiography is an independent risk factor for sudden death due to cardiac arrest. Circulation1991;83:1888-94.
5.
Ahnve S., Gilpin E., Madsen EB et al. Prognostic importance of QTc interval at discharge after acute myocardial infarction: a multicenter study of 865 patients. Am Heart J1984;108:395-400.
6.
Jackman WM, Friday KJ, Anderson JL et al. The long QT syndromes: a critical review, new clinical observations and a unifying hypothesis. Prog Cardiovasc Dis1988;31:115-72.
7.
Day CP, McComb JM, Campbell RWQT dispersion: an indication of arrhythmia risk in patients with long QT intervals . Br Heart J1990;63: 342-4.
8.
Macfarlane PW , McLaughlin SC, Rodger JCInfluence of lead selection and population on automated measurement of QT dispersion. Circulation1998;98:2160-7.
9.
Barr CS, Nass A., Freeman M., Lang CC, Struthers ADQT dispersion and sudden unexpected death in chronic heart failure . Lancet1994; 343:327-9.
10.
Darbar D., Luck J., Davidson N., Pringle T., Main G., McNeill G., Struthers ADSensitivity and specificity of QTc dispersion for identification of risk of cardiac death in patients with peripheral vascular disease. BMJ1996;312:874-9.
11.
Clarkson PB , Naas AA, McMahon A., MacLeod C., Struthers AD, MacDonald TMQT dispersion in essential hypertension. QJM1995; 88:327-32.
12.
Bujag G., Miorelli M., Turrini P., Melacini P., Nova A.Comparison of QT dispersion in hypertrophic cardiomyopathy between patients with and without ventricular arrhythmias and sudden death. Am J Cardiol1993; 72:973-6.
13.
Glancy JM, Garratt CJ, Woods KLQT dispersion and mortality after myocardial infarction. Lancet1995;345:945-8.
14.
Elming H., Holm E., Jun L. et al. The prognostic value of the QT interval and QT interval dispersion in all-cause and cardiac mortality and morbidity in a population of Danish citizens. Eur Heart J1998;19:1391-400.
15.
Moreno FL, Villanueva MT, Karagounis LA for the TEAM-2 Investigators.A reduction in QT interval dispersion by successful thrombolytic therapy in acute MI. Circulation1994;90:94-100.
16.
Zabel M., Portnoy S., Franz MRElectrocardiographic indexes of dispersion of ventricular repolarization; an isolated heart validation study. J Am Coll Cardiol1995;25:746-52.
17.
Malik M., Batchvarov VNMeasurement, interpretation and clinical potential of QT dispersion . J Am Coll Cardiol2000;36:1749-66.
18.
Veglio M., Giunti S., Stevens LK et al. Prevalence of Q-T Interval Dispersion in Type 1 Diabetes and Its Relation with Cardiac Ischaemia: the EURODIAB IDDM Complications Study Group. Diabetes Care2002;25:702-07.
19.
Veglio M., Bruno G., Borra M. et al. Prevalence of increased QT interval duration and dispersion in type 2 diabetic patients and its relationship with coronary heart disease: a population-based cohort. J Inter Med2002 ;25:317-24.
20.
Glancey MJ, Weston PJ, Bhullar HK et al. Reproducibility and automatic measurement of QT dispersion. Eur Heart J1996;17:1035-9.
21.
Rautaharju PMQT and Dispersion of Ventricular Repolarization: The Greatest Fallacy in Electrocardiography in the 1990s. Circulation1999; 99:2477-8.
22.
Rautaharju PMWhy did QT dispersion die?Cardiac Electrophysiology Review2002;6:295-301.
23.
Veglio M., Borra M., Stevens LK et al. The relationship between QTc interval prolongation and diabetic complications: the EURODIAB IDDM Complication Study Group. Diabetologia1999;42:68-75.
24.
Sivieri R., Veglio M., Chinaglia A. et al. Prevalence of QT prolongation in a type 1 diabetic population and its association with autonomic neuropathy. Diabetic Med1993;10:920-4.
25.
Cardoso C., Salles G., Bloch K. et al. Clinical determinants of increased QT dispersion in patients with diabetes mellitus. Intern J Cardiol2001 ;79:253-62.
26.
Sawicki PT, Meinhold J., Kiwitt S. et al. QT interval dispersion is an important predictor of mortality in NIDDM patients. Diabetes1996;45:128.
27.
Naas AA, Davidson NC, Thompson C., Jung RT, Newton RW, Struthers ADQT and QTc dispersion are accurate predictors of cardiac death in newly diagnosed non-insulin-dependent diabetes: cohort study. BMJ1998;316:745-6.
28.
Dinneen SF, Gerstein HCThe Association of Microalbuminuria and Mortality in Non-Insulin-Dependent Diabetes Mellitus: A Systematic Overview of the Literature. Arch Intern Med1997;157:1413-18.
29.
Ewing DJ, Martyn CN, Young RJ, Clarke BFThe value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care1985;8:491-8.
30.
Report and Recommendations of the San Antonio Conference on Diabetic Neuropathy: American Diabetes Association and American Academy of Neurology (Consensus Statement). Diabetes Care1988;11:592-7.
31.
Whitsel EA, Boyko EJ, Siscovick DSReassessing the role of QTc in the diagnosis of autonomic failure among patients with diabetes: a meta-analysis. Diabetes Care2000;23:241-7.
32.
Bravenboer B., Hendriksen PH, Oey LP et al. Is the corrected QT interval a reliable indicator of the severity of diabetic autonomic neuropathy?Diabetes Care1993;16:1249-53.
33.
Marfella R. , Nappo F., DeAngelis L. et al. The effect of acute hyperglycaemia on QTc duration in healthy men. Diabetologia2000;43:571-5.
34.
Lefrandt JD , Diercks GFH, van Boven AJ et al. High fasting glucose and QTc duration in a large healthy cohort. Diabetologia2000 ;43:1332-4.
35.
Brown DW, Giles WH, Greenlund KJ et al. Impaired fasting glucose, diabetes mellitus, and cardiovascular disease risk factors are associated with prolonged QTc duration. Results from the Third National Health and Nutrition Examination Survey. J Cardiovasc Risk2001;8:227-33.
36.
Marfella R., Rossi F., Giugliano D.Hyperglycaemia and QT interval: time for re-evaluation. Diabetes Nutri Metab2001;14:63-5.
37.
Julu P.Vagolytic effect of diabetes mellitus. Brain1993;116:485-92.
38.
UK Prospective Diabetes Study Group.Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet1998;352:837-53.
39.
Stratton IM, Adler AI, Neil HA et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes [UKPDS 35]: prospective observational study. BMJ2000;321:405-12.
40.
Lawson ML, Gerstein HC, Tsui E. et al. Effect of intensive therapy on early macrovascular disease in young individuals with type 1 diabetes. Diabetes Care1999;22:B35-B39.
41.
Day CP, McComb JM, Matthews J. et al. Reduction in QT dispersion by sotalol following myocardial infarction . Eur Heart J1991;12:423-7.
42.
Rana BS, Band MM, Ogston S., Morris AD, Pringle SD, Struthers ADRelation of QT interval dispersion to the number of different cardiac abnormalities in diabetes mellitus. Am J Cardiol2002;90:483-7.
43.
Najeed SA, Khan IA, Molnar J. et al. Differential effect of glyburide (glibenclamide) and metformin on QT dispersion: a potential adenosine triphosphate sensitive K+ channel effect. Am J Cardiol2002;90:1103-06.
